Loading institutional data...
Loading institutional data...
Held by 183 of 6,047 reporting institutions (90th percentile) — extremely crowded.
Data as of Q2 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $24.64 today, the market must believe free cash flow compounds 0.3%/yr for a decade (off $55.6M normalized FCF).
The market's 0.3% is more conservative than its 3-yr track record.
2-stage DCF · 0.01B shares · net debt $310.5M
mean 28.7% · volatility σ 42% · implied rate exceeded in 2/3 yrs
Central path = implied 0.3%/yr growth; shaded band = ±1σ (42%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
EOD close · as of 2026-10-02
How a revenue dollar becomes profit — FY2025
Dividends and buybacks are cash paid out, shown here against the same year's profit for scale — not funded from it.
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.12B 100.0% | $900.2M 100.0% | $672.5M 100.0% | $985.0M 100.0% | $1.10B 100.0% | $910.0M 100.0% | $1.11B 100.0% | $764.9M 100.0% | $617.7M 100.0% | $384.4M 100.0% |
| Cost of Revenue | $42.5M 3.8% | $36.1M 4.0% | $38.8M 5.8% | $57.8M 5.9% | $57.3M 5.2% | $54.5M 6.0% | $68.4M 6.2% | $36.4M 4.8% | $17.2M 2.8% | $13.8M 3.6% |
| Gross Profit | $352.0M 31.5% | $309.6M 34.4% | $289.8M 43.1% | $368.9M 37.5% | $410.4M 37.4% | $369.5M 40.6% | $432.3M 39.1% | $305.1M 39.9% | $251.4M 40.7% | — |
| Research & Development | $45.3M 4.0% | $46.4M 5.1% | $47.2M 7.0% | $55.6M 5.6% | $52.9M 4.8% | $43.6M 4.8% | $40.0M 3.6% | $27.0M 3.5% | $17.9M 2.9% | $13.8M 3.6% |
| Selling, General & Admin | $112.9M 10.1% | $108.7M 12.1% | $117.7M 17.5% | $152.4M 15.5% | $153.5M 14.0% | $129.1M 14.2% | $116.8M 10.6% | $101.2M 13.2% | $71.5M 11.6% | $37.2M 9.7% |
| Total Operating Expenses | $1.05B 94.2% | $855.6M 95.0% | $713.1M 106.0% | $1.02B 103.3% | $1.09B 99.3% | $916.6M 100.7% | $1.06B 95.4% | $708.7M 92.7% | $584.6M 94.6% | $332.3M 86.4% |
| Operating Income | $64.8M 5.8% | $44.6M 5.0% | -$40.6M -6.0% | -$32.8M -3.3% | $8.0M 0.7% | -$6.6M -0.7% | $50.7M 4.6% | $56.2M 7.3% | $33.1M 5.4% | $52.1M 13.6% |
| Interest Expense | — | — | — | $26.0M 2.6% | $46.9M 4.3% | $36.3M 4.0% | $20.3M 1.8% | $12.4M 1.6% | $7.0M 1.1% | $561K 0.1% |
| Other Income (Expense), net | $3.0M 0.3% | -$54.2M -6.0% | -$106.0M -15.8% | $3.8M 0.4% | $123.3M 11.2% | — | — | — | — | — |
| Pretax Income | $21.0M 1.9% | -$37.4M -4.2% | -$124.9M -18.6% | -$54.9M -5.6% | $84.4M 7.7% | -$42.5M -4.7% | $31.0M 2.8% | $43.7M 5.7% | $25.7M 4.2% | $51.6M 13.4% |
| Income Tax Expense | -$130.3M -11.7% | $4.3M 0.5% | -$2.5M -0.4% | $133.0M 13.5% | $11.3M 1.0% | -$20.0M -2.2% | -$8.5M -0.8% | -$65.6M -8.6% | $6.3M 1.0% | $20.4M 5.3% |
| Net Income | $151.0M 13.5% | -$42.0M -4.7% | -$122.0M -18.1% | -$188.0M -19.1% | $69.0M 6.3% | -$48.3M -5.3% | — | — | — | — |
| Per Share | ||||||||||
| EPS (Basic) | $11.14 | $-3.14 | $-9.46 | $-14.69 | $5.24 | $-3.71 | $1.39 | $7.72 | $1.30 | $2.33 |
| EPS (Diluted) | $10.78 | $-3.14 | $-9.46 | $-14.69 | $5.05 | $-3.71 | $1.22 | $6.85 | $1.14 | $2.15 |
| Weighted Avg Shares (Basic) | 13.6M | 13.3M | 12.9M | 12.8M | 13.2M | 13.0M | 12.8M | 12.5M | 11.9M | 11.8M |
| Weighted Avg Shares (Diluted) | 14.1M | 13.3M | 12.9M | 12.8M | 13.7M | 13.0M | 14.6M | 14.1M | 13.7M | 12.8M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash conversion lags reported earnings — watch accruals. Lower/negative accruals = higher quality (Sloan).
Coverage data unavailable; leverage falling year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned on $60.7M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A cash-return story — far more went to shareholders than back into the business (mature, low-reinvestment).
Insufficient data. Current ROIC on all capital: 22%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest. Effective rate ~3.2% on $816.0M of debt. Interest last disclosed in FY2022 (no longer broken out).
Cash of $81.1M fully covers short-term debt of $3.9M.
Mostly long-term debt (balance-sheet current vs non-current split). A year-by-year maturity schedule wasn't disclosed for this issuer.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
EOD close · as of 2026-10-02
Where each multiple sits in its own 14-yr range · 2th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
Equity is the year-end figure. On average equity over the two year-ends, ROE is 76.5% — the two diverge when buybacks or issuance move equity during the year.
What the company owes vs. what it holds
This shows debt/cash structure and net leverage. The year-by-year maturity schedule is on the Debt & Leverage tab.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 1.9× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 4.8 | 6.2 | 6.0 | 5.2 | 5.9 | 5.8 | 4.0 | 3.8 |
| Gross Profit | 39.9 | 39.1 | 40.6 | 37.4 | 37.5 | 43.1 | 34.4 | 31.5 |
| R&D | 3.5 | 3.6 | 4.8 | 4.8 | 5.6 | 7.0 | 5.1 | 4.0 |
| SG&A | 13.2 | 10.6 | 14.2 | 14.0 | 15.5 | 17.5 | 12.1 | 10.1 |
| Operating Income | 7.3 | 4.6 | -0.7 | 0.7 | -3.3 | -6.0 | 5.0 | 5.8 |
| Income Tax | -8.6 | -0.8 | -2.2 | 1.0 | 13.5 | -0.4 | 0.5 | -11.7 |
| Net Income | — | — | -5.3 | 6.3 | -19.1 | -18.1 | -4.7 | 13.5 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on TREE: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.